Information:
Fel:
ID
37779
Beskrivning
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms; ODM derived from: https://clinicaltrials.gov/show/NCT01075802
Länk
https://clinicaltrials.gov/show/NCT01075802
Nyckelord
Versioner (1)
- 2019-08-24 2019-08-24 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
24 augusti 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT01075802
Eligibility Breast Cancer NCT01075802
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01075802
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ECOG performance status
Item
ecog performance status ≤ 1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥ 6 months
boolean
C0023671 (UMLS CUI [1])
Early-Stage Breast Carcinoma | Locally advanced breast cancer | Secondary malignant neoplasm of female breast
Item
histologically or cytologically confirmed early, locally advanced or metastatic breast cancer
boolean
C2986665 (UMLS CUI [1])
C3495949 (UMLS CUI [2])
C0346993 (UMLS CUI [3])
C3495949 (UMLS CUI [2])
C0346993 (UMLS CUI [3])
Estrogen receptor positive
Item
oestrogen receptor positive
boolean
C0279754 (UMLS CUI [1])
Tamoxifen Medication started | Tamoxifen U/day
Item
about to start tamoxifen treatment or already on tamoxifen 20mg daily
boolean
C0039286 (UMLS CUI [1,1])
C0451613 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0451613 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Liver function | Renal function
Item
adequate hepatic and renal function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232804 (UMLS CUI [2])
Chemotherapy | Therapeutic radiology procedure
Item
concurrent chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
Pharmaceutical Preparations Changing CYP3A4 Activity | Pharmaceutical Preparations Changing CYP3A5 Activity | Pharmaceutical Preparations Changing CYP2D6 Activity
Item
treatment with medications that may alter cytochrome p450 (cyp450)3a4/5 and cyp2d6 activities
boolean
C0013227 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C3714798 (UMLS CUI [1,3])
C0205177 (UMLS CUI [1,4])
C0013227 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C3714750 (UMLS CUI [2,3])
C0205177 (UMLS CUI [2,4])
C0013227 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C0057223 (UMLS CUI [3,3])
C0205177 (UMLS CUI [3,4])
C0392747 (UMLS CUI [1,2])
C3714798 (UMLS CUI [1,3])
C0205177 (UMLS CUI [1,4])
C0013227 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C3714750 (UMLS CUI [2,3])
C0205177 (UMLS CUI [2,4])
C0013227 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
C0057223 (UMLS CUI [3,3])
C0205177 (UMLS CUI [3,4])
Thrombosis
Item
history of thrombosis
boolean
C0040053 (UMLS CUI [1])
Treatment Compliance Absent
Item
history of non-compliance with previous or current treatment;
boolean
C4319828 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
Medical condition compromises Informed Consent | Mental condition compromises Informed Consent
Item
medical or psychiatric conditions that compromise the patient's ability to give informed consent
boolean
C3843040 (UMLS CUI [1,1])
C2945640 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])
C2945640 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C0021430 (UMLS CUI [2,3])